These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25879313)

  • 1. Diffusion-weighted magnetic resonance imaging in a case of severe classic maple syrup urine disease.
    Xia W; Yang W
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):805-8. PubMed ID: 25879313
    [No Abstract]   [Full Text] [Related]  

  • 2. Age dependence of diffusion-weighted magnetic resonance imaging findings in maple syrup urine disease encephalopathy.
    Sakai M; Inoue Y; Oba H; Ishiguro A; Sekiguchi K; Tsukune Y; Mitomo M; Nakamura H
    J Comput Assist Tomogr; 2005; 29(4):524-7. PubMed ID: 16012312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the diffusion-weighted MRI in the diagnosis and follow-up of encephalopathy caused by maple syrup urine disease in a full-term newborn.
    Ferraz-Filho JR; Floriano VH; Quirici MB; Albuquerque RP; Souza AS
    Arq Neuropsiquiatr; 2009 Sep; 67(3A):719-23. PubMed ID: 19722062
    [No Abstract]   [Full Text] [Related]  

  • 4. Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings.
    Parmar H; Sitoh YY; Ho L
    J Comput Assist Tomogr; 2004; 28(1):93-7. PubMed ID: 14716239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.
    Bindu PS; Shehanaz KE; Christopher R; Pal PK; Ravishankar S
    J Child Neurol; 2007 Jul; 22(7):911-3. PubMed ID: 17715290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI in acute intermittent maple syrup urine disease.
    Di Rocco M; Biancheri R; Rossi A; Allegri AE; Vecchi V; Tortori-Donati P
    Neurology; 2004 Sep; 63(6):1078. PubMed ID: 15452301
    [No Abstract]   [Full Text] [Related]  

  • 7. Teaching NeuroImages: MRI in maple syrup urine disease.
    Bindu PS; Kovoor JM; Christopher R
    Neurology; 2010 Jan; 74(3):e12. PubMed ID: 20083792
    [No Abstract]   [Full Text] [Related]  

  • 8. MRI findings of adult maple syrup urine disease exacerbation.
    Rawal S; Faghfoury H; Krings T
    Can J Neurol Sci; 2013 Mar; 40(2):259-62. PubMed ID: 23419580
    [No Abstract]   [Full Text] [Related]  

  • 9. Maple syrup urine disease encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI.
    Ha JS; Kim TK; Eun BL; Lee HS; Lee KY; Seol HY; Cha SH
    Pediatr Radiol; 2004 Feb; 34(2):163-6. PubMed ID: 14504844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.
    Cheng A; Han L; Feng Y; Li H; Yao R; Wang D; Jin B
    Diagn Interv Radiol; 2017; 23(5):398-402. PubMed ID: 28830848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion magnetic resonance imaging in intermediate form of maple syrup urine disease.
    Sener RN
    J Neuroimaging; 2002 Oct; 12(4):368-70. PubMed ID: 12380485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in visualization of MR diffusion tensor imaging].
    Chen S; Hao L; Jiang G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):724-8. PubMed ID: 18693465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging in Maple Syrup Urine Disease.
    Shah T; Purohit S; Raval M
    Indian J Pediatr; 2018 Oct; 85(10):927-928. PubMed ID: 29744745
    [No Abstract]   [Full Text] [Related]  

  • 14. Pattern of restricted diffusion seen on magnetic resonance imaging in maple syrup urine disease.
    Kar J; Nguyen FN; Moody SB
    Pediatr Neurol; 2013 Dec; 49(6):505-6. PubMed ID: 24080272
    [No Abstract]   [Full Text] [Related]  

  • 15. Altered white matter integrity and development in children with autism: a combined voxel-based morphometry and diffusion imaging study.
    Mengotti P; D'Agostini S; Terlevic R; De Colle C; Biasizzo E; Londero D; Ferro A; Rambaldelli G; Balestrieri M; Zanini S; Fabbro F; Molteni M; Brambilla P
    Brain Res Bull; 2011 Feb; 84(2):189-95. PubMed ID: 21146593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maple syrup urine disease].
    Incesu L; Tasdemir HA; Yazicioglu AK; Belet U; Danaci M
    Radiol Med; 2001 Sep; 102(3):194-6. PubMed ID: 11677467
    [No Abstract]   [Full Text] [Related]  

  • 17. Diffusion-weighted MRI of maple syrup urine disease encephalopathy.
    Cavalleri F; Berardi A; Burlina AB; Ferrari F; Mavilla L
    Neuroradiology; 2002 Jun; 44(6):499-502. PubMed ID: 12070724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging in neonatal maple syrup urine disease.
    Jain P; Sharma S; Sankhyan N; Gupta N; Kabra M; Gulati S
    Indian J Pediatr; 2013 Jan; 80(1):87-8. PubMed ID: 22865353
    [No Abstract]   [Full Text] [Related]  

  • 19. Maple syrup disease presenting as paroxysmal dystonia.
    Temudo T; Martins E; Poças F; Cruz R; Vilarinho L
    Ann Neurol; 2004 Nov; 56(5):749-50. PubMed ID: 15505779
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular characterization of maple syrup urine disease patients from Tunisia.
    Jaafar N; Moleirinho A; Kerkeni E; Monastiri K; Seboui H; Amorim A; Prata MJ; Quental S
    Gene; 2013 Mar; 517(1):116-9. PubMed ID: 23313820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.